MedTrace Logo

Rapid Microaxial Flow Pump Support and Escalation in Patients With Myocardial Infarction Associated Cardiogenic Shock and Persistent Need of Hemodynamic Support

NCT07655479 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 115

Last updated 2026-06-24

No results posted yet for this study

Summary

The aim of this trial is to evaluate whether a structured and time-optimized escalation strategy from a transfemoral microaxial flow-pump (Impella CP™) to the Impella 5.5™ microaxial flow-pump is associated with improved clinical outcomes and fewer adverse events in patients with cardiogenic shock due to acute myocardial infarction

Conditions

  • Cardiogenic Shock Post Myocardial Infarction

Interventions

DEVICE

Escalation to more capable microaxial flow-pump (Impella 5.5)

Rapid escalation from Impella CP to Impella 5.5 within 24 hours post revascularization

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Max Age
77 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-23
Primary Completion
2028-10-31
Completion
2028-10-31
FDA Device
Yes

Countries

  • Germany

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07655479 on ClinicalTrials.gov